Skip to content
Riskpilot
← Back to search
Sign in
Get full access
DECUMED ApS
APS
Active
Advertising protection
CVR 32083560
Skeltoftevej 73, 2800
Kongens Lyngby
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2009 · 17 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
DECUMED ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
33
24
119
41
24
Staff expenses
-0
-0
-0
-0
-0
EBITDA
33
24
119
41
24
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
33
24
119
41
24
Net financials
-0
-5
0
1
-0
Profit before tax
33
19
119
41
23
Tax
-0
-0
8
19
5
Net profit
33
19
111
23
18
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
35
156
293
319
189
Equity
-20
-1
110
133
151
Long-term debt
0
0
0
0
0
Short-term debt
56
158
183
186
38
Total debt
56
158
183
186
38
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2021
2025
Equity ratio
80.0%
This company
38.2%
Market median
+109% vs market
2021
2025
Return on equity
12.0%
This company
18.4%
Market median
+35% vs market
2021
2025
Net profit margin (of gross profit)
76.7%
This company
2021
2025
Asset turnover (of gross profit)
0.13×
This company
2021
2025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on DECUMED ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
